Immune Therapeutics Inc (OTCQB:IMUN)

Data as of Jan 23
 -0.005 / -3.45%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Immune Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat cancer, HIV or AIDS and autoimmune diseases by combating these chronic and often life-threatening diseases through the activation and rebalancing of the body's immune system. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Contact Information

Immune Therapeutics, Inc.
37 North Orange Avenue
Orlando Florida 32801
P:(888) 613-8802
Investor Relations:



Individual stakeholders1.88%
Mutual fund holders--
Other institutional--

Top Executives

Noreen GriffinChief Executive Officer & Director
Seth A. ElliottPresident & Chief Operating Officer
Peter J. AronstamChief Financial Officer
Fengping ShanDirector & Chief Scientific Officer
Angus George DalgleishCMO, Director-Research & Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.